Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | histone deacetylase, putative | 0.0059 | 0.0261 | 1 |
Plasmodium falciparum | perforin-like protein 2 | 0.0133 | 0.0788 | 0.4109 |
Echinococcus multilocularis | histone deacetylase | 0.0059 | 0.0261 | 0.0128 |
Echinococcus multilocularis | macrophage expressed protein | 0.1204 | 0.8375 | 0.8353 |
Mycobacterium ulcerans | NADH dehydrogenase I subunit F | 0.0041 | 0.0135 | 0.5 |
Trypanosoma brucei | histone deacetylase 4 | 0.0059 | 0.0261 | 1 |
Trypanosoma brucei | histone deacetylase 3 | 0.0059 | 0.0261 | 1 |
Loa Loa (eye worm) | histone deacetylase | 0.0059 | 0.0261 | 0.0898 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0236 | 0.0102 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.024 | 0.1542 | 0.1426 |
Plasmodium vivax | perforin-like protein 1 | 0.0133 | 0.0788 | 0.4109 |
Trichomonas vaginalis | NADH-ubiquinone oxidoreductase flavoprotein, putative | 0.0041 | 0.0135 | 0.5 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.024 | 0.1542 | 0.1426 |
Chlamydia trachomatis | hypothetical protein | 0.0133 | 0.0788 | 0.5 |
Echinococcus multilocularis | histone deacetylase 6 | 0.0059 | 0.0261 | 0.0128 |
Plasmodium falciparum | LCCL domain-containing protein | 0.024 | 0.1542 | 1 |
Onchocerca volvulus | 0.024 | 0.1542 | 1 | |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0236 | 0.0716 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0136 | 0.0007 |
Schistosoma mansoni | lipoxygenase | 0.1433 | 1 | 1 |
Trypanosoma brucei | histone deacetylase, putative | 0.0059 | 0.0261 | 1 |
Plasmodium vivax | perforin-like protein 4 | 0.0133 | 0.0788 | 0.4109 |
Schistosoma mansoni | histone deacetylase 4 5 | 0.0059 | 0.0261 | 0.0128 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0236 | 0.0102 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0236 | 0.0102 |
Schistosoma mansoni | polycystin 1-related | 0.024 | 0.1542 | 0.1426 |
Loa Loa (eye worm) | hypothetical protein | 0.024 | 0.1542 | 1 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.024 | 0.1542 | 0.1426 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.024 | 0.1542 | 0.1426 |
Schistosoma mansoni | loxhd1 | 0.024 | 0.1542 | 0.1426 |
Schistosoma mansoni | hypothetical protein | 0.1204 | 0.8375 | 0.8353 |
Trypanosoma cruzi | histone deacetylase, putative | 0.0059 | 0.0261 | 1 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.024 | 0.1542 | 1 |
Plasmodium falciparum | perforin-like protein 1 | 0.0133 | 0.0788 | 0.4109 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase I (chain F) NuoF (NADH-ubiquinone oxidoreductase chain F) | 0.0041 | 0.0135 | 0.5 |
Schistosoma mansoni | lipoxygenase | 0.1002 | 0.6944 | 0.6902 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0236 | 0.0102 |
Loa Loa (eye worm) | hypothetical protein | 0.024 | 0.1542 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0236 | 0.0102 |
Echinococcus multilocularis | histone deacetylase 7 | 0.0059 | 0.0261 | 0.0128 |
Wolbachia endosymbiont of Brugia malayi | NADH dehydrogenase I subunit F | 0.0041 | 0.0135 | 0.5 |
Echinococcus granulosus | histone deacetylase 6 | 0.0059 | 0.0261 | 0.0128 |
Echinococcus granulosus | macrophage expressed protein | 0.1204 | 0.8375 | 0.8353 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.024 | 0.1542 | 0.1426 |
Loa Loa (eye worm) | doublecortin family protein | 0.024 | 0.1542 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0136 | 0.0007 |
Brugia malayi | Doublecortin family protein | 0.024 | 0.1542 | 1 |
Schistosoma mansoni | rab6-interacting | 0.024 | 0.1542 | 0.1426 |
Echinococcus multilocularis | histone deacetylase 6 | 0.0059 | 0.0261 | 0.0128 |
Loa Loa (eye worm) | histone deacetylase 7A | 0.0059 | 0.0261 | 0.0898 |
Trypanosoma cruzi | histone deacetylase, putative | 0.0059 | 0.0261 | 1 |
Trichomonas vaginalis | NADH-ubiquinone oxidoreductase flavoprotein, putative | 0.0041 | 0.0135 | 0.5 |
Plasmodium falciparum | perforin-like protein 4 | 0.0133 | 0.0788 | 0.4109 |
Echinococcus granulosus | histone deacetylase 7 | 0.0059 | 0.0261 | 0.0128 |
Plasmodium vivax | perforin-like protein 3 | 0.0133 | 0.0788 | 0.4109 |
Echinococcus granulosus | histone deacetylase 6 | 0.0059 | 0.0261 | 0.0128 |
Echinococcus multilocularis | RUN | 0.024 | 0.1542 | 0.1426 |
Brugia malayi | Histone deacetylase family protein | 0.0059 | 0.0261 | 0.0898 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0236 | 0.0102 |
Toxoplasma gondii | MAC/Perforin domain-containing protein | 0.0133 | 0.0788 | 1 |
Echinococcus granulosus | RUN | 0.024 | 0.1542 | 0.1426 |
Echinococcus granulosus | histone deacetylase | 0.0059 | 0.0261 | 0.0128 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0236 | 0.0102 |
Schistosoma mansoni | rab6-interacting | 0.024 | 0.1542 | 0.1426 |
Echinococcus multilocularis | histone deacetylase 6 | 0.0059 | 0.0261 | 0.0128 |
Schistosoma mansoni | hypothetical protein | 0.024 | 0.1542 | 0.1426 |
Plasmodium falciparum | perforin-like protein 3 | 0.0133 | 0.0788 | 0.4109 |
Schistosoma mansoni | histone deacetylase hda2 | 0.0059 | 0.0261 | 0.0128 |
Trypanosoma cruzi | histone deacetylase, putative | 0.0059 | 0.0261 | 1 |
Leishmania major | histone deacetylase, putative | 0.0059 | 0.0261 | 1 |
Brugia malayi | Histone deacetylase family protein | 0.0059 | 0.0261 | 0.0898 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.024 | 0.1542 | 0.1426 |
Brugia malayi | hypothetical protein | 0.024 | 0.1542 | 1 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.1433 | 1 | 1 |
Toxoplasma gondii | perforin-like protein PLP1 | 0.0133 | 0.0788 | 1 |
Echinococcus granulosus | histone deacetylase 6 | 0.0059 | 0.0261 | 0.0128 |
Plasmodium vivax | perforin-like protein 5 | 0.0133 | 0.0788 | 0.4109 |
Plasmodium vivax | perforin-like protein 2 | 0.0133 | 0.0788 | 0.4109 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0236 | 0.0716 |
Brugia malayi | hypothetical protein | 0.024 | 0.1542 | 1 |
Onchocerca volvulus | 0.024 | 0.1542 | 1 | |
Schistosoma mansoni | histone deacetylase 4 5 | 0.0059 | 0.0261 | 0.0128 |
Plasmodium falciparum | perforin-like protein 5 | 0.0133 | 0.0788 | 0.4109 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.